Purpose The mix of an mTOR inhibitor with 5-fluorouracil-based anticancer therapy
Purpose The mix of an mTOR inhibitor with 5-fluorouracil-based anticancer therapy is of interest due to preclinical proof synergy between these medications. price (RR) regarding to RECIST 1.0. Supplementary endpoints had been progression-free success, overall success and 1-calendar year success price. Results Altogether, 31 sufferers had CDC47 been enrolled. Median (range) treatment length of time … [Read more…]